StockData
Opthea Ltd logo

Opthea Ltd (CKDXF) stock

CKDXFOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as CYVNY
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Sep 15, 2025Score 0/30
$0.01+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Opthea cash

Cash and short-term investments held at the end of each period.

Opthea's cash was $48.44M at Jun 30, 2025. For fiscal 2025 it was $48.44M, down 71.9% from the year before. The highest annual figure on record is $172.47M in fiscal 2024.

Annual cash

PeriodPeriod endValueChange
FY2025Jun 30, 2025$48.44M-71.9%
FY2024Jun 30, 2024$172.47M+93.4%
FY2023Jun 30, 2023$89.19M+99.8%
FY2022Jun 30, 2022$44.63M-62.2%
FY2021Jun 30, 2021$118.19M+177.1%
FY2020Jun 30, 2020$42.65M+182.0%
FY2019Jun 30, 2019$15.12M-37.2%
FY2018Jun 30, 2018$24.08M–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2025CQ2 2025Jun 30, 2025$48.44M-45.1%
Q4 FY2024CQ2 2024Jun 30, 2024$172.47M+45.9%
Q4 FY2023CQ2 2023Jun 30, 2023$89.19M-42.9%
Q4 FY2022CQ2 2022Jun 30, 2022$44.63M+4.6%
Q2 FY2022CQ4 2021Dec 31, 2021$88.27M+483.8%
Q4 FY2021CQ2 2021Jun 30, 2021$118.19M+390.8%
Q2 FY2021CQ4 2020Dec 31, 2020$156.13M–
Q4 FY2020CQ2 2020Jun 30, 2020$42.65M–
Q4 FY2019CQ2 2019Jun 30, 2019$15.12M–
Q4 FY2018CQ2 2018Jun 30, 2018$24.08M–

More Opthea figures

See a number that looks wrong?